Rapid prototyping and clinical testing of a reusable face shield for health care workers responding to the COVID-19 pandemic

Autor: Deborah Plana, Sherry H. Yu, Arash Mostaghimi, Richard Oakley, Marc-Joseph Antonini, Philip D. Anderson, Christopher Van, Leanne Smith, Nicole R. LeBoeuf, Helen Yang, Amber Fannin, Brandon Beller, Edward W. Boyer, Jacob Freake, Peter K. Sorger, Michael S. Sinha
Přispěvatelé: McGovern Institute for Brain Research at MIT, Harvard University--MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology. Research Laboratory of Electronics
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Med
medRxiv
article-version (status) pre
article-version (number) 1
Med (New York, N.y.)
ISSN: 2666-6340
DOI: 10.1016/j.medj.2020.06.003
Popis: Summary Background Due to supply chain disruption, the COVID-19 pandemic has caused severe shortages in personal protective equipment for health care professionals. Local fabrication based on 3D printing is one way to address this challenge, particularly in the case of products such as protective face shields. No clear path exists, however, for introducing a locally fabricated product into a clinical setting. Methods We describe a research protocol under Institutional Review Board supervision that allowed clinicians to participate in an iterative design process followed by real-world testing in an emergency department. All designs, materials used, testing protocols, and survey results are reported in full to facilitate similar efforts in other clinical settings. Findings Clinical testing allowed the incident command team at a major academic medical center to introduce the locally fabricated face shield into general use in a rapid but well-controlled manner. Unlike standard hospital face shields, the locally fabricated design was intended to be reusable. We discuss the design and testing process and provide an overview of regulatory considerations associated with fabrication and testing of personal protective equipment, such as face shields. Conclusions Our work serves as a case study for robust, local responses to pandemic-related disruption of medical supply chains with implications for health care professionals, hospital administrators, regulatory agencies, and concerned citizens in the COVID-19 and future health care emergencies. Funding : This work was supported by the Harvard MIT Center for Regulatory Sciences, NIH/NCI grants U54-CA225088 and T32-GM007753, and the Harvard Ludwig Center. M.-J.A. is a Friends of McGovern Graduate Fellow.
Context and Significance The COVID-19 pandemic has disrupted medical device supply chains and caused severe shortages in personal protective equipment needed for infection control. To mitigate these shortages, local companies and maker communities have come together to use 3D printing and public domain designs to fabricate protective equipment, such as face shields. However, using unapproved versions of regulated protective equipment in hospitals is problematic. The authors describe the use of a research protocol supervised by an ethical review panel to test a 3D-printed face shield in the emergency department of a major academic medical center and deploy the face shield widely. They make available designs, materials, testing protocols, and provider surveys so that others can reproduce their efforts and make pandemic response more resilient.
Graphical Abstract
Highlights An investigational medical device protocol was used to test a 3D-printed face shield Health care providers preferred our design over hospital-supplied face shields The face shield is reusable, making it ideal for use in COVID-19 response Designs and protocols are provided for others to use at their own institutions
In response to pandemic-related shortages in medical supplies, the authors use an institutional review board-supervised research protocol to clinically test a 3D-printed face shield in a hospital emergency department. This allowed a major academic medical center to incorporate locally manufactured personal protective equipment into the care of COVID-19 patients.
Databáze: OpenAIRE